|
SMAD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.80280013140077E-10 |
| Normal-vs-Stage3 |
1.62703184258817E-12 |
| Normal-vs-Stage4 |
1.62492241884138E-12 |
| Stage1-vs-Stage2 |
9.406000E-01 |
| Stage1-vs-Stage3 |
1.450390E-01 |
| Stage1-vs-Stage4 |
1.492210E-02 |
| Stage2-vs-Stage3 |
2.941000E-01 |
| Stage2-vs-Stage4 |
8.511900E-02 |
| Stage3-vs-Stage4 |
3.247800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.41400000001013E-07 |
| Normal-vs-Asian |
1.96864746726533E-12 |
| Caucasian-vs-AfricanAmerican |
2.027400E-01 |
| Caucasian-vs-Asian |
6.418400E-01 |
| AfricanAmerican-vs-Asian |
3.718000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.687000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
2.43099999999163E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.939200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.125380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.091800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.130800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.720400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.828000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.577800E-03 |
| Classical-VS-Follicular |
2.348800E-01 |
| Classical-VS-Other |
4.576800E-01 |
| Classical-VS-Normal |
3.41138228776572E-12 |
| Tall-VS-Follicular |
1.337560E-01 |
| Tall-VS-Other |
5.972000E-01 |
| Tall-VS-Normal |
1.13242748511766E-14 |
| Follicular-VS-Other |
8.210600E-01 |
| Follicular-VS-Normal |
1.68265401612189E-12 |
| Other-VS-Normal |
3.357900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.55431223447522E-15 |
| N0-vs-N1 |
8.737700E-02 |
|
|
